Key facts
| Price (PPV) | 27 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | fluorouracile |
| Class | Antineoplastic agents |
| ATC code | L01BC02 |
| Manufacturer | NOVOPHARMA |
| Presentation | Boîte unitaire |
| Nature | Médicament |
| Hospital price | 16.90 MAD |
| Data collected on | 9/8/2026 |
Indications
- adénocarcinomes digestifs évolués, - cancers colorectaux après résection en situation adjuvante, - adénocarcinomes mammaires après traitement locorégional ou lors des rechutes, - adénocarcinomes ovariens, - carcinomes épidermoïdes des voies aérodigestives supérieures et œsophagiennes.
Find an open pharmacy
On-call pharmacies near you
About Pharmauracil 250 mg / 10 ml
Pharmauracil 250 mg / 10 ml belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by NOVOPHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Pharmauracil 250 mg / 10 ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Pharmauracil 250 mg / 10 ml
Answers to common questions from Moroccan patients about this drug.